Health Science Policy Council Chair 2019 - 2021

Shelby Reed

Shelby Reed, RPh, PhD

Professor, Duke Clinical Research Institute
Durham, NC, United States

Health Science Policy Council Members

Policy Outlook Committee

Ola Ahmad Al Ahdab, RPh, PhD, BSc

Abu Dhabi, AZ, United Arab Emirates

Pamela Blumberg, DrPH, MPH

VP Value & Access, TriNetX
Cambridge, SC, United States

Lou Garrison, PhD

Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute,
Seattle, WA, United States

Jorge Gómez, MSc, PhD

Senior HE Manager for Vaccines LATAM, GlaxoSmithKline
Victoria, B, Argentina

Jens Grueger, PhD

Director and Partner, Boston Consulting Group
Freiburg, BW, Germany

Finn Børlum Kristensen, PhD, MD

Danish Centre for Health Economics - University of Southern Denmark
Hilleroed, 84, Denmark

Eui-Kyung Lee, RPh, PhD

sungkyunkwan university
Taipei, Taiwan

Newell McElwee, PharmD, MSPH

Vice President HEOR, Boehringer Ingleheim
Ridgefield, CT, United States

Maciej Niewada, MSc, PhD, MD, MA

Professor, ISPOR Poland Chapter
Warsaw, MZ, Poland

Brian O'Rourke, PharmD

Retired Health Care Executive
Ottawa, ON, Canada

Chris Pashos, BS, PhD, MPP

Advisor / consultant, Genesis Research
Winchester, MA, United States

Soualmi Redouane, MSc, PharmD

Head of Market Access & Government Affairs, Boehringer Ingelheim
Ouled Fayet, 16, Algeria

Suzanne Schrandt, JD

Founder, CEO, & Chief Patient Advocate, ExPPect
Washington, DC, United States

Adrian Towse, Mphil, MA

Emeritus Director, Office of Health Economics
London, United Kingdom

Science/Research Committee

Ibrahim Alabbadi, MBA, RPh, PhD, DrPH, BSc

Professor, The University of Jordan
Amman, AM, Jordan

Michael Drummond, PhD

Professor of Health Economics, University of York
York, YOR, United Kingdom

Ana Lucia Hincapie, MSc, PhD

Assistant Professor, University of Cincinnati College of Pharmacy
Cincinatti, OH, United States

Rok Hren, MSc, PhD, BSc

Director, Hren & Partner d.o.o.
Ljubljana, Slovenia

Maarten IJzerman, MSc, PhD

Chair of Cancer Health Services Research, University of Melbourne and University of Twente
Melbourne, VIC, Australia

Khalid Kamal, MS, PhD

Professor, West Virginia University
Morgantown, WV, United States

Paul Kind

Professor, University of Leeds
Leeds, United Kingdom

Vivian Lee, PharmD, BSc

Associate Professor, The Chinese University of Hong Kong
Shatin, Hong Kong

Josephine Mauskopf, PhD

Vice President, Health Economics, RTI Health Solutions
Research Triangle Park, NC, United States

Karen Rascati, RPh, PhD

Professor, University of Texas College of Pharmacy
Austin, TX, United States

Shelby Reed, RPh, PhD

Professor, Duke Clinical Research Institute
Durham, NC, United States

Mark Sculpher, MSc, PhD, BA

University of York
York, NYK, United Kingdom

Marthinus Stander, MBA, MD

Managing Director, VI Research FZ-LLC
Dubai, DU, United Arab Emirates

Task Force Review Committee

Federico Augustovski, MSc, PhD, MD

Director, HTA, (IECS) Institute for Clinical Effectiveness and Health Policy
Buenos Aires, Argentina

Marc Berger, MD

Marc L. Berger, LLC
New York, NY, United States

Reed Johnson, PhD

Professor, Duke School of Medicine, Duke Clinical Research Institute
Durham, NC, United States

C. Daniel Mullins, PhD

University of Maryland Baltimore
Baltimore, MD, United States

Donald Patrick, PhD, MSPH

Professor Emeritus, University of Washington
Seattle, WA, United States

Scott Ramsey, PhD, MD

Full Member & Co-Director, Fred Hutchinson Cancer Research Center
Seattle, WA, United States

Mark S. Roberts, MD, MPP

Professor and Chair, Health Policy and Management, University of Pittsburgh
Pittsburgh, PA, United States
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now